2Ishidoya S,Morrissey J,McCracken R,et al.Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy[].Kidney International.1996
3Zoja C,Morigi M,Figliuzzi M,et al.Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins[].American Journal of Kidney Diseases.1995
4Sintchak MD,Fleming MA,Futer 0,et al.Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid[].Cell.1996
5Sollinger HW.Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients.U. S. Renal Transplant Mycophenolate Mofetil Study Group[].Transplantation.1995
6Ruth Z,Steinmann-niggli K,Kappeler A,et al.Mycophenolic acid: a new approach to therapy of experimental mesangial proliferative glomerulonephritis[].Journal of the American Society of Nephrology.1998
7Cherif B,Vincent M,McGregor B,et al.Mycophenolate mofetil reduces myofibroblast infiltration and collgen Ⅲ deposition in rat remnant kidney[].Kidney International.2000
8Corna D,Morigi M,Facchinetti D,et al.Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease[].Kidney International.1997
9Raisanen-Sokolowski A,Vuoristo P,MyllArniemi M,et al.Mycophenolate mofetil(MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts[].Transplant Immunology.1995
